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ABSTRACT 
Through the specific identification and direct targeting of cancer stem cells (CSCs), it is 
believed that a better treatment efficacy of cancer may be achieved. Hence, the present study 
aimed to identify a CSC subpopulation from adenocarcinoma cells (A549) as a model of non-
small cell lung cancer (NSCLC). Initially, we sorted two subpopulations known as the triple-
positive (EpCAM+/CD166+/CD44+) and triple-negative (EpCAM−/CD166−/CD44−) 
subpopulation using fluorescence-activated cell sorting (FACS). Sorted cells were 
subsequently evaluated for proliferation and chemotherapy-resistance using a viability assay 
and were further characterized for their clonal heterogeneity, self-renewal characteristics, 
cellular migration, alkaline dehydrogenase (ALDH) activity and the expression of stemness-
related genes. According to our findings the triple-positive subpopulation revealed 
significantly higher (P<0.01) proliferation activity, exhibited better clonogenicity, was mostly 
comprised of holoclones and had markedly bigger (P<0.001) spheroid formation indicating a 
better self-renewal capacity. A relatively higher resistance to both 5-fluouracil and cisplatin 
with 80% expression of ALDH was observed in the triple-positive subpopulation, compared to 
only 67% detected in the triple-negative subpopulation indicated that high ALDH activity 
contributed to greater chemotherapy-resistance characteristics. Higher percentage of migrated 
cells was observed in the triple-positive subpopulation with 56% cellular migration being 
detected, compared to only 19% in the triplenegative subpopulation on day 2. This was 
similarly observed on day 3 in the triple-positive subpopulation with 36% higher cellular 
migration compared to the triple-negative subpopulation. Consistently, elevated levels of the 
stem cell genes such as REX1 and SSEA4 were also found in the triple-positive subpopulation 
indicating that the subpopulation displayed a strong characteristic of pluripotency. In 
conclusion, our study revealed that the triple-positive subpopulation demonstrated similar 
characteristics to CSCs compared to the triple-negative subpopulation. It also confirmed the 
feasibility of using the triple-positive (EpCAM+/CD166+/CD44+) marker as a novel candidate 
marker that may lead to the development of novel therapies targeting CSCs of NSCLC. 
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